STEX
Streamex Corp.
Company overview
- Market capitalization
- $82.08M
- Employees
- 6
- Latest publication
- 2026-09-29
About Streamex Corp.
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market. In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 146,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 13,000USD | 0USD |
| Selling General Administrative | 13,836,000USD | 34,254,000USD | 40,164,000USD | 4,619,000USD | 19,792,000USD | 2,957,000USD | 1,070,000USD | 2,763,000USD |
| General And Administrative Expenses | 13,836,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 15,307,000USD | 34,254,000USD | 43,674,000USD | 4,625,000USD | 20,365,000USD | 2,984,000USD | 1,196,000USD | 2,950,000USD |
| Operating Income | -15,161,000USD | -35,746,000USD | -41,632,000USD | -6,113,000USD | -20,365,000USD | -2,984,000USD | -1,183,000USD | -2,950,000USD |
| Total Other Income Expense Net | 105,000USD | -11,513,000USD | -382,865,000USD | -10,236,000USD | -3,000USD | 184,000USD | 84,000USD | 1,036,000USD |
| Net Interest Income | -3,000USD | -12,195,000USD | -1,595,000USD | -10,000USD | 13,000USD | 0USD | -3,000USD | 0USD |
| Income Before Tax | -15,056,000USD | -47,259,000USD | -424,497,000USD | -16,349,000USD | -20,368,000USD | -2,800,000USD | -1,099,000USD | -1,914,000USD |
| Income Tax Expense | -505,000USD | -566,000USD | -474,000USD | -765,000USD | — | — | — | — |
| Net Income | -14,551,000USD | -46,693,000USD | -424,007,000USD | -15,584,000USD | -20,372,000USD | -2,812,000USD | -1,099,000USD | -1,914,000USD |
| Minority Interest | 1,000USD | 1,000USD | 1,000USD | 0USD | -4,000USD | -12,000USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | -14,554,000USD | — | — | — | — | — | — | — |
| Cost Of Revenue | — | 1,492,000USD | -2,042,000USD | 1,488,000USD | 554,000USD | — | — | — |
| Gross Profit | — | -1,492,000USD | 2,042,000USD | -1,488,000USD | -554,000USD | — | 13,000USD | — |
| Research Development | — | 0USD | 0USD | 6,000USD | 19,000USD | 6,000USD | 96,000USD | 156,000USD |
| Interest Expense | — | 12,195,000USD | 16,000USD | 10,000USD | — | 0USD | 3,000USD | — |
| Tax Provision | — | -565,000USD | -489,000USD | -765,000USD | 0USD | 0USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | -46,694,000USD | -424,009,000USD | -15,584,000USD | -20,368,000USD | -2,800,000USD | -1,099,000USD | -1,914,000USD |
| Ebit | — | -35,746,000USD | -432,961,000USD | -16,339,000USD | -20,365,000USD | -2,800,000USD | -3,377,000USD | -2,950,000USD |
| Ebitda | — | -34,254,000USD | -431,492,000USD | -14,851,000USD | -19,809,000USD | -2,779,000USD | -3,347,000USD | -2,919,000USD |
| Depreciation And Amortization | — | 1,492,000USD | 1,469,000USD | 1,488,000USD | 556,000USD | 21,000USD | 30,000USD | 31,000USD |
| Reconciled Depreciation | — | 1,492,000USD | 1,469,000USD | 1,488,000USD | 556,000USD | 21,000USD | 30,000USD | 31,000USD |
| Unclassified Operating Expenses | — | — | 3,510,000USD | — | — | — | — | — |
| Interest Income | — | — | — | — | 13,000USD | — | — | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 40,000USD | 18,000USD | 286,000USD | 441,000USD | — |
| Research Development | 31,000USD | 832,000USD | 5,092,000USD | 5,821,000USD | 5,602,000USD | 13,253,110USD |
| Selling General Administrative | 67,529,000USD | 11,629,000USD | 23,077,000USD | 21,380,000USD | 27,853,000USD | — |
| Unclassified Operating Expenses | 3,534,000USD | — | — | — | — | 40,498,000USD |
| Total Operating Expenses | 71,094,000USD | 12,902,000USD | 28,530,000USD | 27,494,000USD | 33,653,000USD | 53,751,110USD |
| Operating Income | -71,094,000USD | -12,862,000USD | -28,512,000USD | -27,265,000USD | -33,411,000USD | -54,301,110USD |
| Interest Expense | 1,592,000USD | 11,000USD | — | — | — | — |
| Net Interest Income | -1,592,000USD | -11,000USD | 9,000USD | 3,000USD | 2,000USD | — |
| Income Before Tax | -464,014,000USD | -10,339,000USD | -28,690,000USD | -27,262,000USD | -32,856,000USD | -59,140,000USD |
| Income Tax Expense | -1,239,000USD | — | — | — | — | — |
| Tax Provision | -1,254,000USD | 0USD | 0USD | 0USD | 0USD | — |
| Net Income | -462,775,000USD | -10,330,000USD | -29,041,000USD | -27,052,000USD | -31,917,000USD | -52,218,000USD |
| Net Income From Continuing Ops | -462,760,000USD | -10,339,000USD | -28,690,000USD | -27,262,000USD | -32,856,000USD | — |
| Ebit | -462,422,000USD | -12,609,000USD | -28,512,000USD | -27,265,000USD | -33,411,000USD | -59,140,000USD |
| Ebitda | -458,888,000USD | -12,421,000USD | -28,151,000USD | -26,972,000USD | -33,213,000USD | -58,590,000USD |
| Depreciation And Amortization | 3,534,000USD | 188,000USD | 361,000USD | 293,000USD | 198,000USD | 550,000USD |
| Reconciled Depreciation | 3,534,000USD | 188,000USD | 361,000USD | 293,000USD | 198,000USD | — |
| Total Other Income Expense Net | -392,920,000USD | 2,523,000USD | -178,000USD | 3,000USD | 555,000USD | -4,838,890USD |
| Minority Interest | -15,000USD | 9,000USD | -351,000USD | 210,000USD | 939,000USD | — |
| Gross Profit | — | 40,000USD | 18,000USD | 229,000USD | 242,000USD | -550,000USD |
| Cost Of Revenue | — | — | 0USD | 57,000USD | 199,000USD | 550,000USD |
| Interest Income | — | — | 9,000USD | 3,000USD | 2,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 159,584,000USD | 173,317,000USD | 187,543,000USD | 130,514,000USD | 109,721,000USD | 4,418,000USD | 842,000USD | 1,418,000USD |
| Cash And Equivalents | 5,605,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 18,466,000USD | 30,625,000USD | 30,022,000USD | 11,045,000USD | 2,820,000USD | 3,727,000USD | 155,000USD | 654,000USD |
| Short Term Investments | 12,861,000USD | 23,766,000USD | 9,706,000USD | 0USD | 0USD | 0USD | 13,000USD | 39,000USD |
| Total Current Assets | 34,551,000USD | 45,904,000USD | 71,895,000USD | 14,992,000USD | 3,001,000USD | 3,986,000USD | 344,000USD | 848,000USD |
| Other Non Current Assets | 15,464,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 12,368,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,710,000USD | 3,302,000USD | 42,794,000USD | 125,600,000USD | 113,200,000USD | 1,679,000USD | 2,264,000USD | 1,701,000USD |
| Total Stockholder Equity | 145,614,000USD | 158,985,000USD | 133,191,000USD | -6,854,000USD | -3,512,000USD | 2,710,000USD | -1,439,000USD | -300,000USD |
| Total Equity Including Noncontrolling Interest | 147,111,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 806,000USD | 12,000USD | 25,000USD | 38,000USD | 67,000USD | 123,000USD | 185,000USD | 252,000USD |
| Goodwill | 68,521,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 40,242,000USD | 42,418,000USD | 44,639,000USD | 45,410,000USD | 47,917,000USD | 265,000USD | 270,000USD | 274,000USD |
| Accounts Payable | 1,455,000USD | — | — | — | — | — | — | — |
| Short Term Debt | 129,000USD | — | 38,021,000USD | — | 15,000USD | 60,000USD | 102,000USD | 145,000USD |
| Common Stock | 113,000USD | 98,000USD | 50,000USD | 36,000USD | 31,000USD | 24,000USD | 17,000USD | 17,000USD |
| Retained Earnings | -779,365,000USD | -764,813,000USD | -718,120,000USD | -294,113,000USD | -278,529,000USD | -258,157,000USD | -255,345,000USD | -254,246,000USD |
| Accumulated Other Comprehensive Income | -2,968,000USD | -1,102,000USD | 814,000USD | -787,000USD | 1,538,000USD | — | — | — |
| Other Current Assets | — | 15,279,000USD | 41,873,000USD | 3,897,000USD | 152,000USD | 150,000USD | 80,000USD | 113,000USD |
| Total Liab | — | 13,971,000USD | 54,215,000USD | 137,335,000USD | 113,200,000USD | 1,679,000USD | 2,264,000USD | 1,701,000USD |
| Other Current Liab | — | 3,302,000USD | 4,773,000USD | 125,600,000USD | 113,185,000USD | 1,619,000USD | 2,162,000USD | 1,556,000USD |
| Capital Stock | — | 203,000USD | 155,000USD | 141,000USD | 136,000USD | 129,000USD | 122,000USD | 122,000USD |
| Good Will | — | 69,758,000USD | 70,984,000USD | 69,888,000USD | 58,692,000USD | — | 0USD | — |
| Cash | — | 6,859,000USD | 20,316,000USD | 11,045,000USD | 2,820,000USD | 3,727,000USD | 142,000USD | 615,000USD |
| Net Debt | — | -6,859,000USD | 17,705,000USD | -11,045,000USD | -2,805,000USD | -3,667,000USD | -40,000USD | -470,000USD |
| Property Plant Equipment Gross | — | 1,036,000USD | 1,036,000USD | 1,538,000USD | 1,538,000USD | 1,538,000USD | 1,542,000USD | 1,542,000USD |
| Common Stock Shares Outstanding | — | 47,966,169shares | 47,966,169shares | 33,352,004shares | 27,706,780shares | 20,787,808shares | 17,414,778shares | 16,200,928shares |
| Non Current Assets Total | — | 127,413,000USD | 115,648,000USD | 115,522,000USD | 106,720,000USD | 432,000USD | 498,000USD | 570,000USD |
| Non Current Liabilities Total | — | 10,669,000USD | 11,421,000USD | 11,735,000USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 15,225,000USD | — | 44,000USD | 44,000USD | 44,000USD | 43,000USD | 44,000USD |
| Net Working Capital | — | 42,602,000USD | 29,101,000USD | -110,608,000USD | -110,199,000USD | 2,307,000USD | -1,920,000USD | -853,000USD |
| Unclassified Non Current Liabilities | — | 10,669,000USD | 11,421,000USD | 11,735,000USD | — | — | — | — |
| Unclassified Equity | — | 924,599,000USD | 850,292,000USD | 287,869,000USD | 273,312,000USD | 260,714,000USD | 253,767,000USD | 253,807,000USD |
| Short Long Term Debt | — | — | 38,021,000USD | — | — | — | — | — |
| Short Long Term Debt Total | — | — | 38,021,000USD | — | 15,000USD | 60,000USD | 102,000USD | 145,000USD |
| Net Receivables | — | — | 0USD | 50,000USD | 29,000USD | 109,000USD | 109,000USD | 81,000USD |
| Unclassified Current Liabilities | — | — | -38,021,000USD | — | — | — | — | — |
| Long Term Investments | — | — | — | 142,000USD | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 187,543,000USD | 842,000USD | 1,798,000USD | 4,110,000USD | 15,519,000USD | 30,386,000USD |
| Intangible Assets | 44,639,000USD | 270,000USD | 289,000USD | 308,000USD | 327,000USD | 347,000USD |
| Other Current Assets | 41,873,000USD | 80,000USD | 211,000USD | 325,000USD | 354,000USD | 301,000USD |
| Total Liab | 54,215,000USD | 2,264,000USD | 4,685,000USD | 3,713,000USD | 2,954,000USD | 5,109,000USD |
| Total Stockholder Equity | 133,191,000USD | -1,439,000USD | -2,913,000USD | 418,000USD | 12,346,000USD | 24,475,000USD |
| Other Current Liab | 4,773,000USD | 2,162,000USD | 4,217,000USD | 2,943,000USD | 2,261,000USD | 4,795,000USD |
| Common Stock | 50,000USD | 17,000USD | 9,000USD | 5,000USD | 36,000USD | 31,000USD |
| Capital Stock | 155,000USD | 122,000USD | 114,000USD | 110,000USD | 141,000USD | — |
| Retained Earnings | -718,120,000USD | -255,345,000USD | -245,015,000USD | -215,974,000USD | -188,922,000USD | -157,005,000USD |
| Good Will | 70,984,000USD | 0USD | — | — | — | — |
| Cash | 20,316,000USD | 142,000USD | 190,000USD | 357,000USD | 11,659,000USD | 28,268,000USD |
| Cash And Short Term Investments | 30,022,000USD | 155,000USD | 293,000USD | 458,000USD | 11,659,000USD | 28,268,000USD |
| Total Current Assets | 71,895,000USD | 344,000USD | 528,000USD | 1,128,000USD | 13,894,000USD | 29,337,000USD |
| Total Current Liabilities | 42,794,000USD | 2,264,000USD | 4,582,000USD | 3,261,000USD | 2,576,000USD | 5,108,000USD |
| Net Debt | 17,705,000USD | -40,000USD | 262,000USD | 408,000USD | -11,003,000USD | -27,954,000USD |
| Short Term Debt | 38,021,000USD | 102,000USD | 349,000USD | 313,000USD | 283,000USD | 313,000USD |
| Short Long Term Debt | 38,021,000USD | — | — | — | — | — |
| Short Long Term Debt Total | 38,021,000USD | 102,000USD | 452,000USD | 765,000USD | 656,000USD | 314,000USD |
| Short Term Investments | 9,706,000USD | 13,000USD | 103,000USD | 101,000USD | 0USD | — |
| Net Receivables | 0USD | 109,000USD | 24,000USD | 9,000USD | 0USD | — |
| Property Plant Equipment Net | 25,000USD | 185,000USD | 938,000USD | 1,490,000USD | 1,256,000USD | 595,000USD |
| Property Plant Equipment Gross | 1,036,000USD | 1,542,000USD | 2,464,000USD | 2,381,000USD | 1,784,000USD | — |
| Accumulated Other Comprehensive Income | 814,000USD | — | — | — | — | — |
| Common Stock Shares Outstanding | 47,966,169shares | 14,041,748shares | 7,351,794shares | 4,307,244shares | 3,351,194shares | 2,790,658shares |
| Non Current Assets Total | 115,648,000USD | 498,000USD | 1,270,000USD | 2,982,000USD | 1,625,000USD | 1,048,999USD |
| Non Current Liabilities Total | 11,421,000USD | 0USD | 103,000USD | 452,000USD | 378,000USD | 1,000USD |
| Net Working Capital | 29,101,000USD | -1,920,000USD | -4,054,000USD | -2,133,000USD | 11,318,000USD | — |
| Unclassified Current Liabilities | -38,021,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | 11,421,000USD | — | — | — | — | — |
| Unclassified Equity | 850,292,000USD | 253,767,000USD | 241,979,000USD | 216,277,000USD | 201,091,000USD | 181,449,000USD |
| Non Currrent Assets Other | — | 43,000USD | 43,000USD | 1,184,000USD | 42,000USD | 106,999USD |
| Current Deferred Revenue | — | — | 16,000USD | 5,000USD | 32,000USD | — |
| Inventory | — | — | 0USD | 336,000USD | 1,881,000USD | 768,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 2,963,000USD |
| Stock Based Compensation | 32,487,000USD |
| Deferred Income Tax | -1,070,000USD |
| Other Non Cash Items | -3,057,000USD |
| Change To Liabilities | -572,000USD |
| Change In Working Capital | -7,573,000USD |
| Operating Cash Flow | -21,918,000USD |
| Net Investments | -2,897,000USD |
| Unclassified Investing Cash Flow | 12,060,000USD |
| Investing Cash Flow | 9,163,000USD |
| Financing Cash Flow | -1,882,000USD |
| Effect Of Forex Changes On Cash | -74,000USD |
| Change In Cash | -14,711,000USD |
| End Cash Flow | 5,605,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -46,693,000USD | -424,004,000USD | -15,584,000USD | -20,372,000USD | -2,800,000USD | -1,099,000USD | -1,940,000USD | -3,911,000USD |
| Depreciation | 1,492,000USD | 1,471,000USD | 1,488,000USD | 554,000USD | 21,000USD | 30,000USD | 31,000USD | 49,000USD |
| Stock Based Compensation | 25,370,000USD | 55,030,000USD | 842,000USD | 5,370,000USD | 2,074,000USD | -53,000USD | 1,517,000USD | 4,432,000USD |
| Other Non Cash Items | 36,739,000USD | 369,156,000USD | 11,102,000USD | 12,374,000USD | 240,000USD | -4,864,000USD | 2,529,000USD | -1,310,000USD |
| Change To Account Receivables | 2,000USD | -24,000USD | -22,000USD | -7,000USD | 17,000USD | -2,000USD | -27,000USD | -14,000USD |
| Change In Working Capital | -1,152,000USD | -4,185,000USD | -1,264,000USD | 6,166,000USD | -650,000USD | 5,512,000USD | -5,040,000USD | -741,000USD |
| Total Cash From Operating Activities | -10,179,000USD | -3,021,000USD | -5,023,000USD | -1,278,000USD | -1,115,000USD | -474,000USD | -1,489,000USD | -1,481,000USD |
| Capital Expenditures | -14,225,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -24,404,000USD | -3,021,000USD | -5,023,000USD | -1,278,000USD | -1,115,000USD | -474,000USD | -1,489,000USD | -1,481,000USD |
| Investments | -13,710,000USD | -24,472,000USD | -145,000USD | — | 0USD | 0USD | 0USD | 0USD |
| Total Cashflows From Investing Activities | -1,500,000USD | -24,471,000USD | -145,000USD | 366,000USD | — | — | — | — |
| Net Borrowings | -38,500,000USD | 45,364,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | -1,637,000USD | 36,780,000USD | 13,396,000USD | 0USD | 4,700,000USD | 1,000USD | 0USD | 3,169,000USD |
| Dividends Paid | -2,000USD | -11,000USD | — | — | — | — | — | — |
| Issuance Of Capital Stock | 37,184,000USD | 1,000USD | 13,572,000USD | 0USD | 4,700,000USD | 1,000USD | 0USD | 3,169,000USD |
| Change In Cash | -13,457,000USD | 9,271,000USD | 8,225,000USD | -907,000USD | 3,585,000USD | -473,000USD | -1,489,000USD | 1,688,000USD |
| Begin Period Cash Flow | 20,316,000USD | 11,045,000USD | 2,820,000USD | 3,727,000USD | 142,000USD | 615,000USD | 2,104,000USD | 416,000USD |
| End Period Cash Flow | 6,859,000USD | 20,316,000USD | 11,045,000USD | 2,820,000USD | 3,727,000USD | 142,000USD | 615,000USD | 2,104,000USD |
| Other Cashflows From Investing Activities | 12,185,000USD | — | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | -1,635,000USD | 36,614,000USD | — | — | — | — | — | — |
| Unclassified Operating Cash Flow | -25,935,000USD | — | -1,607,000USD | -5,370,000USD | — | — | 1,414,000USD | — |
| Unclassified Investing Cash Flow | 14,250,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 1,316,000USD | -55,671,000USD | — | — | — | — | — | — |
| Sale Purchase Of Stock | — | 10,484,000USD | — | — | — | — | — | — |
| Change To Inventory | — | — | — | — | — | 0USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -462,760,000USD | -10,339,000USD | -28,690,000USD | -27,262,000USD | -32,856,000USD | -52,218,000USD |
| Depreciation | 3,534,000USD | 188,000USD | 361,000USD | 293,000USD | 198,000USD | 550,000USD |
| Stock Based Compensation | 57,104,000USD | 6,957,000USD | 7,978,000USD | 4,412,000USD | 9,500,000USD | — |
| Other Non Cash Items | 392,872,000USD | -1,927,000USD | 2,269,000USD | 388,000USD | 209,000USD | 22,716,000USD |
| Change To Account Receivables | -36,000USD | 18,000USD | 86,000USD | -229,000USD | 0USD | — |
| Change In Working Capital | 67,000USD | 363,000USD | 769,000USD | 464,000USD | -3,450,000USD | 2,351,000USD |
| Total Cash From Operating Activities | -10,437,000USD | -4,758,000USD | -17,313,000USD | -21,705,000USD | -26,399,000USD | -26,601,000USD |
| Capital Expenditures | 0USD | 0USD | -186,000USD | -168,000USD | -542,000USD | -87,000USD |
| Free Cash Flow | -10,437,000USD | -4,758,000USD | -17,499,000USD | -21,873,000USD | -26,941,000USD | -26,688,000USD |
| Investments | -24,616,000USD | 0USD | -186,000USD | -168,000USD | -542,000USD | — |
| Total Cashflows From Investing Activities | -24,250,000USD | — | -186,000USD | -168,000USD | -542,000USD | -87,000USD |
| Net Borrowings | 45,364,000USD | 500,000USD | 0USD | — | — | — |
| Total Cash From Financing Activities | 54,876,000USD | 4,710,000USD | 17,332,000USD | 10,571,000USD | 10,332,000USD | 42,847,000USD |
| Dividends Paid | -11,000USD | — | — | — | — | — |
| Sale Purchase Of Stock | 10,484,000USD | — | — | — | — | — |
| Issuance Of Capital Stock | 18,273,000USD | 4,210,000USD | 15,361,000USD | 10,353,000USD | 10,304,000USD | — |
| Change In Cash | 20,174,000USD | -48,000USD | -167,000USD | -11,302,000USD | -16,609,000USD | 16,159,418USD |
| Begin Period Cash Flow | 142,000USD | 190,000USD | 357,000USD | 11,659,000USD | 28,268,000USD | 12,108,582USD |
| End Period Cash Flow | 20,316,000USD | 142,000USD | 190,000USD | 357,000USD | 11,659,000USD | 28,268,000USD |
| Other Cashflows From Financing Activities | -701,000USD | — | 1,971,000USD | 218,000USD | 28,000USD | — |
| Unclassified Operating Cash Flow | -1,254,000USD | — | — | — | — | — |
| Change To Inventory | — | 0USD | -498,000USD | 284,000USD | -1,114,000USD | -287,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2023Quarterly · 2023-03-31 | Segment | Corporate | 5,000 | USD | 0001185185-23-000516 |
| Q1 2023Quarterly · 2023-03-31 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | 0001185185-23-000516 |
| Q1 2023Quarterly · 2023-03-31 | Segment | Viral Clear | 0 | USD | 0001185185-23-000516 |
| Q4 2022Quarterly · 2022-12-31 | Segment | Corporate | 135,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Segment | Viral Clear | 0 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Product | Product | 254,000 | USD | 0001493152-24-014860 |
| FY 2022Yearly · 2022-12-31 | Product | Services | 32,000 | USD | 0001493152-24-014860 |
| FY 2022Yearly · 2022-12-31 | Segment | Corporate | 286,000 | USD | 0001185185-23-000298 |
| FY 2022Yearly · 2022-12-31 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | 0001185185-23-000298 |
| FY 2022Yearly · 2022-12-31 | Segment | Viral Clear | 0 | USD | 0001185185-23-000298 |
| Q3 2022Quarterly · 2022-09-30 | Segment | Corporate | 135,000 | USD | 0001185185-22-001305 |
| Q3 2022Quarterly · 2022-09-30 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | 0001185185-22-001305 |
| Q3 2022Quarterly · 2022-09-30 | Segment | Viral Clear | 0 | USD | 0001185185-22-001305 |
| Q3 2022Quarterly · 2022-09-30 | Product | Product | 127,000 | USD | 0001493152-23-041256 |
| Q3 2022Quarterly · 2022-09-30 | Product | Services | 8,000 | USD | 0001493152-23-041256 |
| Q2 2022Quarterly · 2022-06-30 | Segment | Bio Sig AI | 0 | USD | 0001185185-23-000845 |
| Q2 2022Quarterly · 2022-06-30 | Segment | Corporate | 8,000 | USD | 0001185185-23-000845 |
| Q2 2022Quarterly · 2022-06-30 | Segment | Viral Clear | 0 | USD | 0001185185-23-000845 |
| Q1 2022Quarterly · 2022-03-31 | Segment | Corporate | 8,000 | USD | 0001185185-23-000516 |
| Q1 2022Quarterly · 2022-03-31 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | 0001185185-23-000516 |
| Q1 2022Quarterly · 2022-03-31 | Segment | Viral Clear | 0 | USD | 0001185185-23-000516 |
| Q4 2021Quarterly · 2021-12-31 | Segment | Corporate | 8,000 | USD | Legacy provider |
| Q4 2021Quarterly · 2021-12-31 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | Legacy provider |
| Q4 2021Quarterly · 2021-12-31 | Segment | Viral Clear | 0 | USD | Legacy provider |
| FY 2021Yearly · 2021-12-31 | Product | Product | 414,000 | USD | 0001185185-23-000298 |
| FY 2021Yearly · 2021-12-31 | Product | Services | 27,000 | USD | 0001185185-23-000298 |
| FY 2021Yearly · 2021-12-31 | Segment | Corporate | 441,000 | USD | 0001185185-23-000298 |
| FY 2021Yearly · 2021-12-31 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | 0001185185-23-000298 |
| FY 2021Yearly · 2021-12-31 | Segment | Viral Clear | 0 | USD | 0001185185-23-000298 |
| Q4 2021Quarterly · 2021-12-31 | Product | Product | 0 | USD | Legacy provider |
| Q4 2021Quarterly · 2021-12-31 | Product | Services | 8,320 | USD | Legacy provider |
| Q3 2021Quarterly · 2021-09-30 | Segment | Corporate | 108,000 | USD | 0001185185-22-001305 |
| Q3 2021Quarterly · 2021-09-30 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | 0001185185-22-001305 |
| Q3 2021Quarterly · 2021-09-30 | Segment | Viral Clear | 0 | USD | 0001185185-22-001305 |
| Q3 2021Quarterly · 2021-09-30 | Product | Product | 100,000 | USD | 0001185185-22-001305 |
| Q3 2021Quarterly · 2021-09-30 | Product | Services | 8,000 | USD | 0001185185-22-001305 |
| Q2 2021Quarterly · 2021-06-30 | Segment | Corporate | 207,000 | USD | 0001185185-22-000932 |
| Q2 2021Quarterly · 2021-06-30 | Segment | Neuro Clear Technologies Inc Neuro Clear | 0 | USD | 0001185185-22-000932 |
| Q2 2021Quarterly · 2021-06-30 | Segment | Viral Clear | 0 | USD | 0001185185-22-000932 |
| Q2 2021Quarterly · 2021-06-30 | Product | Product | 199,000 | USD | 0001185185-21-001099 |
| Q2 2021Quarterly · 2021-06-30 | Product | Services | 8,000 | USD | 0001185185-21-001099 |
| Q1 2021Quarterly · 2021-03-31 | Product | Product | 115,367 | USD | 0001185185-21-000686 |
| Q1 2021Quarterly · 2021-03-31 | Product | Services | 2,680 | USD | 0001185185-21-000686 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.